Z-0834-2021 Class II Ongoing
FDA device recall Z-0834-2021 was initiated by Fresenius Medical Care Holdings, Inc. on Nov 23, 2020 and is designated Class II. Reason for recall: The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium… The recall status is ongoing. Affected quantity: 278 cases.
Recall details
- Product Type
- Devices
- Report Date
- Jan 20, 2021
- Initiation Date
- Nov 23, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 278 cases
Product description
Citrasate Liquid Acid concentrate bottles, Product Code 08-2251-CA - Product Usage: used in conjunction with Fresenius Renal Technologies Sodium Bicarbonate Concentrate in a compatible 45X dilution three-stream artificial kidney (hemodialysis) machine.
Reason for recall
The deviation in conductivity for sodium level exceeds 0.6mS/cm from the theoretical conductivity (TCD) or approximately 6mEq/L of sodium from prescriptions that was previously communicated. Calcium concentration is below manufacturing specification.
Distribution pattern
US Nationwide distribution.
Code information
Lot Numbers: 20NXAC007 Additional Affected lots as of 3/17/21: 20NXAC007
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0834-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026